glp-1 manufacturers in india Did you know? is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up diabetes & obesity care #MarketTalks #EdelweissMutualFund India Enhances Oversight on GLP-1

In a large study, patients who had at least one dietitian visit were more likely to be checked for deficiencies and get the guidance they needed

Not generic wellness advice

PUBLICIDAD PUBLICIDAD

Results: Recent evidence from phase 2 clinical trials for MASH demonstrated that pharmacological agents based on GLP-1 receptor agonism are effective in improving disease activity

MeAgain is the better fit for daily GLP-1 follow-through across shots, food, symptoms, weight, and medication context

For Pfizer, it opens a renewed path back into obesity and diabetes therapeuticsareas expected to exceed $100 billion in annual revenue by 2030